The 2019 World Cancer Leaders' Summit was hosted by the Kazakh Institute of Oncology and Radiology (KazIOR) from Tuesday 15 to Thursday 17 October in Nur-Sultan, Kazakhstan.
350 global influencers and leaders in cancer control and public health from 82 countries and from across governments, UN agencies, academia, non-profit organisations and private sectors considered the ways in which cancer detection, treatment and care contribute to the achievement of Universal Health Coverage.
The event was open to UICC full members, partners and select leaders from the global health and cancer communities, by invitation only and without registration fees. We are pleased to share the full gallery of photos of the event.
Cancer and Universal Health Coverage (UHC)
Reducing the number of premature deaths caused by cancer requires addressing inequities in access to cancer services to achieve the UHC vision of "Health for All". With “Cancer and Universal Health Coverage” as a topic, the 2019 edition of the World Cancer Leaders’ Summit aimed to focus attention on expanding access to quality preventive, early detection, treatment and care for cancer. Issues examined included perspectives on the relationship between strong, sustainable and ‘people centred’ health systems and the effective prevention and control of NCDs, promoting health equity in access to cancer services, and priority setting as part of the progressive realization of UHC.
Dr Cary Adams, CEO of UICC, read out a call to action at the conclusion of the main summit day.
Read it in full by clicking the link below.
Robert Yates, Head of UHC Policy Forum, Centre on Global Health Security
Ahmedin Jemal, Scientific Vice President, Surveillance and Health Services Research, American Cancer Society (ACS)
Filip Meheus, Health Economist, International Agency for Research on Cancer (IARC)
Exploring the effective use of law to achieve Universal Health Coverage
Regional approaches: Universal Health Coverage and Cancer
Big data, advanced analytics and personalised cancer care
Making the national investment case for cervical cancer elimination